Purple Biotech Ltd. (PPBT)
Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 64
-0.05
-2.9586%
After Hours
$
+0.19 +11.5854% 1. 83
233.36K Market Cap
- P/E Ratio
- Div Yield
89,369 Volume
-0.92 Eps
$ 1.69
Previous Close Analysts:
Want to track PPBT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Purple Biotech Ltd. (PPBT) Statistics
Valuation metrics
Market Cap 233.36K
Enterprise value -3.59M
Trailing P/E (ttm) -0.24
Forward P/E -3.07
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.65
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.48
Overview
Shares outstanding 1.86B
Float 1.85B
Shares short 10.48K
% Held by insiders 0.07%
% Held by institutions 0.11%
Average volume (10 days) 1.82M
Average volume (90 days) 320.42K
Price summary
52-Week low 1.42
52-Week high 29
Beta -0.57
50-Day moving average 3.58
200-Day moving average 5.31
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 2 Mar 2026
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.79%
Return on equity -1.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -59K
EBITDA -6.97M
Net income to common (ttm) -26.39M
Diluted EPS (ttm) -0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 9.57M
Total cash per share (mrq) 0
Total debt (mrq) 244K
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 1.48%
Book value per share (mrq) 0.01
Cash Flow
Cash flow statement -5.66M
Levered free cash flow (LFCF) -54K
